Our Blog
Keep up to date with our latest conversations, discussions and stories – together we can transform clinical cancer care
AARC Annual Meeting 2021 – An overview
Event expiration date display - 13 MAY 2021
Greg Jones our Sr Director, Medical Affairs provides an overview of the growing evidence for ctDNA changing how we detect residual disease and recurrence read more
Motivated by a meaningful purpose: Tim Forshew, Co-founder and Head of Science and Innovation, Inivata
Event expiration date display - 26 APR 2021
Tim talks us through the founding of Inivata and how Nitzan Rosenfeld inspired him to join the team. read more
Product Development from the eyes of an R&D Scientist
Event expiration date display - 23 APR 2021
Creative and bold individuals make up Inivata. Garima Sharma shares her insights into RaDaR development and how the team have worked together to build an industry-leading liquid biopsy test. read more
LBx Summit 2021 review and thoughts
Event expiration date display - 23 FEB 2021
Yanin Naiyachit, Product Manager – Liquid Biopsy Applications here at Inivata, shares his thoughts and key take-aways from the recent LBx Summit 2021. read more
Alan Schafer our new CTO discusses the potential of personalized liquid biopsy in clinical trial development and recruitment
Event expiration date display - 11 NOV 2020
Find out more about the potential of personalized liquid biopsy in clinical trial development and recruitment read more
“Liquid biopsy: a key piece in the diagnostic jigsaw puzzle” by Peter Collins, Chief Business Officer, Inivata
Event expiration date display - 11 NOV 2020
We recently welcomed Peter Collins to Inivata as our new CBO, find out more here read more
Sarah Perrey DeGeare in our Lab Operations team talks about what it’s like to be part of #TeamInivata
Event expiration date display - 09 NOV 2020
Find out what it is like to be part of our team. read more
The start of Lung Cancer Awareness Month 2020
Event expiration date display - 01 NOV 2020
Today marks the start of Lung Cancer Awareness Month, a critical point in time for all those working on any aspect of this devastating disease to stop, think and remind ourselves why we’re doing ... read more
Jenni Westoby joined our Bioinformatics Team eight months ago and is really enjoying being part of the team.
Event expiration date display - 21 JUL 2020
Find out more about her first few months with us. read more
AACR 2020 Summary: Demonstrating a sensitive and specific personalized assay to detect residual disease and recurrence
Event expiration date display - 07 JUL 2020
This year’s annual meeting of the American Association for Cancer Research (AACR) was converted into an entirely virtual experience focused on clinical data as a result of the COVID-19 pandemic. ... read more
Sophie Hackinger in our bioinformatics team discusses the reasons she joined Inivata – I wanted to build products that would have a direct impact on patients’ lives.
Event expiration date display - 20 APR 2020
I started out with an undergraduate degree in biomedical sciences, which was more wet lab focused. What really fascinated me about human biology was how the combination of multiple genetic and ... read more
The development of a highly sensitive test for detecting residual disease and recurrence in cancer patients
Event expiration date display - 21 JUL 2020
As cells die in our body, they release DNA into our blood stream. This cell free DNA (cfDNA) can come from many sources, including healthy cells such as white blood cells. In individuals with ... read more
Anna Farne, Senior Software Developer at Inivata tells us more about how her role in software development is helping transforming the lives of cancer patients around the world.
Event expiration date display - 7 APR 2020
During my first role working as a lab technician I became interested in IT and how it fits into a science and research environment. There were nice software tools for data analysis, LIMS systems ... read more
Tim Forshew, Co-founder and Head of Science and Innovation at Inivata shares his thoughts on a recent publication from groups at Dana-Farber, Broad Institute and Boston University that demonstrate the value of personalized assays for detecting ctDNA with high sensitivity.
Event expiration date display - 1 APR 2020
Thoughts on Parsons et al 2020 – a new study on the value of personalized ctDNA assays for residual disease and recurrence detection read more
Warren Emmett, Computational Genomics Team Lead at Inivata talks about how his role in bioinformatics is helping lung cancer patients.
Event expiration date display - 04 MAR 2020
I started out with an undergrad in Human Genetics and after doing a tutorial on the BLAST algorithm I fell in love with bioinformatics, and the potential it held for changing biology. After ... read more
The critical importance of sensitivity and how inivata’s technology is expanding the reach of liquid biopsy into new clinical and pharmaceutical applications.
Event expiration date display - 28 JAN 2020
Antony Newton, VP Business Development, talks about the critical importance of sensitivity and how Inivata’s technology is expanding the reach of liquid biopsy into new clinical and ... read more
Pioneering and focused on making a difference to cancer management – liquid biopsy.
Event expiration date display - 13 NOV 2019
Liquid biopsy offers the potential to transform the way physicians manage cancer and deliver significant benefits to patients by guiding and personalizing treatment, monitoring response and ... read more
A personal passion for innovation and to make a difference to cancer care.
Event expiration date display - 31 OCT 2019
Nitzan Rosenfeld, CSO and Co-founder, Inivata talks about the personal story behind his scientific career and his path to making fundamental breakthroughs in liquid biopsyWhat drove you towards ... read more
